Point of Care Diagnostics Market Size- By Product, By platform, By Sample, By Purchase, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Point of Care Diagnostics Market Size- By Product, By platform, By Sample, By Purchase, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Point of Care Diagnostics Market Introduction and Overview

According to SPER market research, ‘Global Point of Care Diagnostics Market Size- By Product, By platform, By Sample, By Purchase, By End Use – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ state that the Global Point of Care Diagnostics Market is predicted to reach 134.92 billion by 2034 with a CAGR of 9.61%.

The market for point-of-care (POC) diagnostics includes procedures and equipment used close to patient care that offer prompt results to support clinical judgment. The need for quick diagnostics, chronic illnesses, and technological advancements are what drive growth. Molecular diagnostics, immunoassays, and lateral flow tests are important technologies. The market is also growing due to self-testing and home care.

Restraints: Price pressure may result from fierce competition in the POC testing market. Additionally, manufacturers’ profit margins are being severely impacted by declining POC test reimbursement rates from government payers, private insurers, or healthcare reimbursement programs, which is having a major effect on the expansion of the point-of-care diagnostics market. The adoption of point-of-care testing may be hampered by healthcare facilities’ limited finances for purchasing point-of-care testing supplies and equipment, particularly those located in underdeveloped or financially strapped areas.

Scope of the Report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered By Product, By platform, By Sample, By purchase, By End Use.

Regions covered

North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Companies Covered

Abbott, AccuBioTech Co., Ltd, ALPHA LABORATORIES, Anbio Biotechnology Co., Ltd., Becton Dickinson (BD), bioMerieux, Danaher Corporation, EKF Diagnostics Holdings plc., F. Hoffmann-La Roche Ltd., Nova Biomedical, Orasure Technologies, Inc., Siemens Healthcare GmbH, Spectral Medical, Inc., and others.

Point of Care Diagnostics Market Segmentation:

By Product: Based on the Product, Global Point of Care Diagnostics Market is segmented as; Glucose, HIV, Hep C, HPV, Hematology, Pregnancy.

By Platform: Based on the Platform, Global Point of Care Diagnostics Market is segmented as; Asthma, COPD, Other Diseases.

By Sample: Based on the Sample, Global Point of Care Diagnostics Market is segmented as; Blood, Urine.

By Purchase: Based on the Purchase, Global Point of Care Diagnostics Market is segmented as; OTC, Rx.

By End Use: Based on the End Use, Global Point of Care Diagnostics Market is segmented as; Hospitals, Homecare Settings, Other Settings.

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.